98 related articles for article (PubMed ID: 1630816)
21. Functional analysis of the N-terminal domain of the Myc oncoprotein.
Oster SK; Mao DY; Kennedy J; Penn LZ
Oncogene; 2003 Apr; 22(13):1998-2010. PubMed ID: 12673205
[TBL] [Abstract][Full Text] [Related]
22. The C. elegans MDL-1 and MXL-1 proteins can functionally substitute for vertebrate MAD and MAX.
Yuan J; Tirabassi RS; Bush AB; Cole MD
Oncogene; 1998 Sep; 17(9):1109-18. PubMed ID: 9764821
[TBL] [Abstract][Full Text] [Related]
23. Synergistic induction of the Fas (CD95) ligand promoter by Max and NFkappaB in human non-small lung cancer cells.
Wiener Z; Ontsouka EC; Jakob S; Torgler R; Falus A; Mueller C; Brunner T
Exp Cell Res; 2004 Sep; 299(1):227-35. PubMed ID: 15302589
[TBL] [Abstract][Full Text] [Related]
24. c-Myc does not require max for transcriptional activity in PC-12 cells.
Ribon V; Leff T; Saltiel AR
Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
[TBL] [Abstract][Full Text] [Related]
25. Lack of transcriptional repression by max homodimers.
Yin X; Grove L; Prochownik EV
Oncogene; 1998 May; 16(20):2629-37. PubMed ID: 9632139
[TBL] [Abstract][Full Text] [Related]
26. Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism.
Buckle RS; Méchali M
Oncogene; 1995 Mar; 10(6):1249-55. PubMed ID: 7700652
[TBL] [Abstract][Full Text] [Related]
27. The N-myc oncoprotein is a transcriptional activator and associates with max and RB1 proteins.
Wenzel A; Cziepluch C; Schürmann J; Schwab M
Prog Clin Biol Res; 1994; 385():59-66. PubMed ID: 7972238
[No Abstract] [Full Text] [Related]
28. Intracellular leucine zipper interactions suggest c-Myc hetero-oligomerization.
Dang CV; Barrett J; Villa-Garcia M; Resar LM; Kato GJ; Fearon ER
Mol Cell Biol; 1991 Feb; 11(2):954-62. PubMed ID: 1990293
[TBL] [Abstract][Full Text] [Related]
29. Max: functional domains and interaction with c-Myc.
Kato GJ; Lee WM; Chen LL; Dang CV
Genes Dev; 1992 Jan; 6(1):81-92. PubMed ID: 1730412
[TBL] [Abstract][Full Text] [Related]
30. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants.
Mukherjee B; Morgenbesser SD; DePinho RA
Genes Dev; 1992 Aug; 6(8):1480-92. PubMed ID: 1644290
[TBL] [Abstract][Full Text] [Related]
31. Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells.
Barrett J; Birrer MJ; Kato GJ; Dosaka-Akita H; Dang CV
Mol Cell Biol; 1992 Jul; 12(7):3130-7. PubMed ID: 1620120
[TBL] [Abstract][Full Text] [Related]
32. Basal levels of max are sufficient for the cotransformation of C3H10T1/2 cells by ras and myc.
Davenport EA; Taparowsky EJ
Exp Cell Res; 1992 Oct; 202(2):532-40. PubMed ID: 1397104
[TBL] [Abstract][Full Text] [Related]
33. An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation.
Brough DE; Hofmann TJ; Ellwood KB; Townley RA; Cole MD
Mol Cell Biol; 1995 Mar; 15(3):1536-44. PubMed ID: 7862146
[TBL] [Abstract][Full Text] [Related]
34. Overproduction of v-Myc in the nucleus and its excess over Max are not required for avian fibroblast transformation.
Tikhonenko AT; Hartman AR; Linial ML
Mol Cell Biol; 1993 Jun; 13(6):3623-31. PubMed ID: 8497274
[TBL] [Abstract][Full Text] [Related]
35. Mutations within the 5' half of the avian retrovirus MC29 v-myc gene alter or abolish transformation of chicken embryo fibroblasts and macrophages.
Farina SF; Huff JL; Parsons JT
J Virol; 1992 May; 66(5):2698-708. PubMed ID: 1313895
[TBL] [Abstract][Full Text] [Related]
36. The Adrenomedullin gene is a target for negative regulation by the Myc transcription complex.
Wang X; Peters MA; Utama FE; Wang Y; Taparowsky EJ
Mol Endocrinol; 1999 Feb; 13(2):254-67. PubMed ID: 9973255
[TBL] [Abstract][Full Text] [Related]
37. B-myc inhibits neoplastic transformation and transcriptional activation by c-myc.
Resar LM; Dolde C; Barrett JF; Dang CV
Mol Cell Biol; 1993 Feb; 13(2):1130-6. PubMed ID: 8423780
[TBL] [Abstract][Full Text] [Related]
38. Control of the Myc-Max mediated transactivation in yeast by natural promoter elements.
Hänel F; Peukert K; Munder T
J Basic Microbiol; 1997; 37(1):23-8. PubMed ID: 9090124
[TBL] [Abstract][Full Text] [Related]
39. The Myc negative autoregulation mechanism requires Myc-Max association and involves the c-myc P2 minimal promoter.
Facchini LM; Chen S; Marhin WW; Lear JN; Penn LZ
Mol Cell Biol; 1997 Jan; 17(1):100-14. PubMed ID: 8972190
[TBL] [Abstract][Full Text] [Related]
40. Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions.
Prendergast GC; Hopewell R; Gorham BJ; Ziff EB
Genes Dev; 1992 Dec; 6(12A):2429-39. PubMed ID: 1459463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
